Among these model mrlncRNAs, lncRNA of ALMS1-IT1 can accelerate tumor malignant progression (e.g., lung adenocarcinoma) via AVL9-mediated activation of the cyclin-dependent kinase pathway [30]. This evidence concerns the gene AVL9 and lung adenocarcinoma.